Exercise Rehabilitation in Veteran Cancer Survivors
Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.
Checked against the public recordLast updated Feb 18, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- VA Office of Research and Development
- Interventions being studied
- Behavioral: Exercise Rehabilitation; Other: Control
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Age 60-80 years 2. Diagnosis with lung cancer 3. History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both 4. Completion of thoracotomy or chemotherapy \> or = 6 months 5. Ability to walk on a treadmill 6. Karnofsky performance status \> 70 7. Score \> 1 Neuropathic Pain Scale Exclusion Criteria: 1. Presence of metastatic (stage IV) 2. Life expectancy \< 6 months 3. Musculoskeletal or medical conditions which preclude participation in an exercise program
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MDBaltimore, Maryland
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 18, 2026. Always confirm current availability with the study team.